Clinical trials
Observational Non-Muscle Invasive Bladder Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
48 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 1 |
| 2011 | 2 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 6 |
| 2020 | 5 |
| 2021 | 3 |
| 2022 | 4 |
| 2023 | 9 |
| 2024 | 2 |
| 2025 | 3 |
| 2026 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 16 |
| Recruiting | 16 |
| Unknown status | 7 |
| Active, not recruiting | 3 |
| Not yet recruiting | 3 |
| Terminated | 3 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Mansoura University | 3 |
| Endo USA Inc., a Keenova Therapeutics Company | 2 |
| Oslo University Hospital | 2 |
| Peking University First Hospital | 2 |
| Photocure | 2 |
| Universitaire Ziekenhuizen KU Leuven | 2 |
| University of Washington | 2 |
| Aarhus University Hospital | 1 |
| Ain Shams University | 1 |
| Arquer Diagnostics Ltd | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Non-Muscle Invasive Bladder Neoplasms | 48 |
| Urinary Bladder Neoplasms | 31 |
| Recurrence | 9 |
| Disease Progression | 8 |
| Carcinoma, Transitional Cell | 4 |
| Hematuria | 2 |
| Neoplasms | 2 |
| Urinary Bladder Diseases | 2 |
| Carcinoma | 1 |
| Disease | 1 |
Trials
Showing 76 to 48 of 48. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.